• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顽固性高血压:评估与治疗概述

Resistant hypertension: an overview of evaluation and treatment.

作者信息

Sarafidis Pantelis A, Bakris George L

机构信息

Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

出版信息

J Am Coll Cardiol. 2008 Nov 25;52(22):1749-57. doi: 10.1016/j.jacc.2008.08.036.

DOI:10.1016/j.jacc.2008.08.036
PMID:19022154
Abstract

Resistant hypertension is defined as failure to achieve goal blood pressure (BP) when a patient adheres to the maximum tolerated doses of 3 antihypertensive drugs including a diuretic. Although the exact prevalence of resistant hypertension is currently unknown, indirect evidence from population studies and clinical trials suggests that it is a relatively common clinical problem. The prevalence of resistant hypertension is projected to increase, owing to the aging population and increasing trends in obesity, sleep apnea, and chronic kidney disease. Management of resistant hypertension must begin with a careful evaluation of the patient to confirm the diagnosis and exclude factors associated with "pseudo-resistance," such as improper BP measurement technique, the white-coat effect, and poor patient adherence to life-style and/or antihypertensive medications. Education and reinforcement of life-style issues that affect BP, such as sodium restriction, reduction of alcohol intake, and weight loss if obese, are critical in treating resistant hypertension. Exclusion of preparations that contribute to true BP treatment resistance, such as nonsteroidal anti-inflammatory agents, cold preparations, and certain herbs, is also important. Lastly, BP control can only be achieved if an antihypertensive treatment regimen is used that focuses on the genesis of the hypertension. An example is volume overload, a common but unappreciated cause of treatment resistance. Use of the appropriate dose and type of diuretic provides a solution to overcome treatment resistance in this instance.

摘要

顽固性高血压的定义为,患者坚持服用包括利尿剂在内的3种最大耐受剂量的抗高血压药物时,血压仍未达到目标值。虽然目前尚不清楚顽固性高血压的确切患病率,但来自人群研究和临床试验的间接证据表明,这是一个相对常见的临床问题。由于人口老龄化以及肥胖、睡眠呼吸暂停和慢性肾病的增加趋势,顽固性高血压的患病率预计将会上升。顽固性高血压的管理必须从对患者进行仔细评估开始,以确认诊断并排除与“假性耐药”相关的因素,如不当的血压测量技术、白大衣效应以及患者对生活方式和/或抗高血压药物的依从性差等。对影响血压的生活方式问题进行教育和强化,如限制钠摄入、减少酒精摄入以及肥胖者减轻体重等,对于治疗顽固性高血压至关重要。排除导致真正血压治疗抵抗的制剂,如非甾体抗炎药、感冒药和某些草药,也很重要。最后,只有采用针对高血压病因的抗高血压治疗方案才能实现血压控制。例如容量超负荷,这是导致治疗抵抗的一个常见但未被充分认识的原因。在这种情况下,使用适当剂量和类型的利尿剂可提供克服治疗抵抗的解决方案。

相似文献

1
Resistant hypertension: an overview of evaluation and treatment.顽固性高血压:评估与治疗概述
J Am Coll Cardiol. 2008 Nov 25;52(22):1749-57. doi: 10.1016/j.jacc.2008.08.036.
2
Resistant systemic hypertension.耐药性系统性高血压。
J Cardiovasc Med (Hagerstown). 2011 May;12(5):340-2. doi: 10.2459/JCM.0b013e328343e9e0.
3
Current options for the treatment of resistant hypertension.难治性高血压的当前治疗选择。
Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1385-93. doi: 10.1586/erc.09.120.
4
Treatment of hypertension in chronic kidney disease.慢性肾脏病高血压的治疗
Semin Nephrol. 2005 Nov;25(6):435-9. doi: 10.1016/j.semnephrol.2005.05.016.
5
[Resistant hypertension].[顽固性高血压]
Rev Med Chil. 2008 Apr;136(4):528-38. Epub 2008 Jun 16.
6
Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.联合治疗优化高血压管理:执业护士的考量因素
J Cardiovasc Nurs. 2009 Sep-Oct;24(5):380-9. doi: 10.1097/JCN.0b013e3181aed18e.
7
Evaluation and management of the patient with difficult-to-control or resistant hypertension.难治性或顽固性高血压患者的评估与管理
Am Fam Physician. 2009 May 15;79(10):863-9.
8
Treatment resistant hypertension.难治性高血压
Am J Ther. 2008 Jul-Aug;15(4):351-5. doi: 10.1097/MJT.0b013e318164c67b.
9
Recent update in the management of hypertension.高血压管理的最新进展。
Acta Med Indones. 2007 Oct-Dec;39(4):186-91.
10
Identifying and managing factors that interfere with or worsen blood pressure control.识别和管理干扰或加重血压控制的因素。
Postgrad Med. 2010 Mar;122(2):35-48. doi: 10.3810/pgm.2010.03.2120.

引用本文的文献

1
Long-acting nifedipine in the management of essential hypertension: a review for cardiologists.长效硝苯地平在原发性高血压治疗中的应用:心血管科医生的综述
Am J Cardiovasc Dis. 2024 Dec 15;14(6):396-413. doi: 10.62347/RPMZ6407. eCollection 2024.
2
Characterizing apparent treatment resistant hypertension in the United States: insights from the All of Us Research Program.美国显性难治性高血压的特征分析:来自“我们所有人”研究计划的见解
J Am Med Inform Assoc. 2024 Dec 1;31(12):2899-2907. doi: 10.1093/jamia/ocae227.
3
Multispectral brain connectivity during visual attention distinguishes controlled from uncontrolled hypertension.
多光谱脑连接在视觉注意期间区分受控和不受控的高血压。
J Physiol. 2024 Apr;602(8):1775-1790. doi: 10.1113/JP285568. Epub 2024 Mar 22.
4
Effect of Continuous Positive Airway Pressure on Blood Pressure in Patients with Resistant Hypertension and Obstructive Sleep Apnea: An Updated Meta-analysis.持续气道正压通气对难治性高血压合并阻塞性睡眠呼吸暂停患者血压的影响:一项更新的荟萃分析。
Curr Hypertens Rep. 2024 May;26(5):201-211. doi: 10.1007/s11906-024-01294-4. Epub 2024 Mar 9.
5
A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension.2023 年欧洲高血压学会(ESH)动脉高血压管理指南的肾脏病实践欧洲肾脏协会(ERA)概要
Nephrol Dial Transplant. 2024 May 31;39(6):929-943. doi: 10.1093/ndt/gfae041.
6
Whole genome sequence analysis of apparent treatment resistant hypertension status in participants from the Trans-Omics for Precision Medicine program.精准医学跨组学计划参与者中明显治疗抵抗性高血压状态的全基因组序列分析。
Front Genet. 2023 Dec 13;14:1278215. doi: 10.3389/fgene.2023.1278215. eCollection 2023.
7
Arterial Hypertension-clinical trials update 2023.高血压临床研究 2023 年更新
Hypertens Res. 2023 Sep;46(9):2159-2167. doi: 10.1038/s41440-023-01359-y. Epub 2023 Jul 13.
8
The epithelial sodium channel in inflammation and blood pressure modulation.炎症与血压调节中的上皮钠通道
Front Cardiovasc Med. 2023 Apr 12;10:1130148. doi: 10.3389/fcvm.2023.1130148. eCollection 2023.
9
Effects of Sacubitril/Valsartan on resistant hypertension and myocardial work in hemodialysis patients.沙库巴曲缬沙坦对透析患者难治性高血压及心肌做功的影响。
J Clin Hypertens (Greenwich). 2022 Mar;24(3):300-308. doi: 10.1111/jch.14422. Epub 2022 Jan 31.
10
Computed tomography-guided chemical renal sympathetic nerve modulation in the treatment of resistant hypertension: A case report.计算机断层扫描引导下化学性肾交感神经调制治疗顽固性高血压:一例报告。
World J Clin Cases. 2021 Nov 16;9(32):9970-9976. doi: 10.12998/wjcc.v9.i32.9970.